Horse-assisted Interventions in an Oncological Centre

Sex: All

Ages: 16 Years – 65 Years

Healthy volunteers: No

Phase: NA

Enrollment: 28

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Location: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS Meldola FC

Summary

This study is a non-pharmacological, controlled, randomized interventional study with two arms: standard onco-hematology therapy compared with standard therapy associated with the Equine-Assisted Therapy (EAT).

Eligibility Criteria

Inclusion Criteria: * Adolescents-Young adults (16 - 39 years old) of both sexes with onco-hematological cancer at any stage who have completed chemotherapy and/or radiotherapy at least 3 months before enrolment * Women (18 - 65 years) with breast cancer who have completed chemotherapy and/or radiotherapy at least 3 months before enrolment * ECOG PS 0-1 * Written informed consent * Subjects who don't practice any other equestrian sport * Life expectancy greater than 6 months * Subjects who are able to understand the study and cooperate according to study procedures, based on Investigator's opinion. Exclusion Criteria: * Horse Allergy * Critical Bone lesions * Moderate to severe neutropenia * Moderate to severe Thrombocytopenia * ECOG PS\>2 * Uncontrolled epilepsy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07831460). StuddyBuddy aggregates publicly available trial information.